NCT01347983 - Extension Study of Tocilizumab Long Term Treatment of Moderate to Severe Rheumatoid Arthritis Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

March 31, 2013

Study Completion Date

April 30, 2013

Conditions

Rheumatoid Arthritis

Interventions

DRUG

Tocilizumab+Methotrexate(MTX)

Tocilizumab: 8 mg/kg every 4 weeks, IV infusion Methotrexate: 10-20 mg/week

Trial Locations (12)

Buddhist Dalin Tzu Chi General Hospital, Chiayi City

Chang Gung Memorial Hospital -Kaohsiung, Kaohsiung City

Kaohsiung Medical University Hospital, Kaohsiung City

Kaohsiung Veterans General Hospital, Kaohsiung City

Chung Shan Medical University Hospital, Taichung

Taichung Veterans General Hospital, Taichung

National Cheng Kung University Hospital, Tainan City

Cathay General Hospital, Taipei

National Taiwan University Hospital, Taipei

Taipei Veterans General Hospital, Taipei

Tri-Service General Hospital, Taipei

Chang Gung Memorial Hospital - Linkou, Taoyuan District